GlassScriptPhysician profile
Robert F Deuell
NPI 1407894959
$807.85
in general payments reported to CMS, 2019-2025
16 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.53 · 2021: $19.09 · 2022: $86.16 · 2023: $144 · 2024: $166 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $142.17 | 2023-2025 | |
| Abbott Laboratories | $119.22 | 2021-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $98.65 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Corcept Therapeutics | $88.20 | 2025 | Korlym |
| Novo Nordisk INC | $85.51 | 2023-2025 | Wegovy |
| Abbvie INC. | $59.18 | 2022-2024 | Ubrelvy |
| Springworks Therapeutics, INC. | $39.01 | 2025 | Gomekli |
| Amgen INC. | $34.76 | 2024-2025 | Otezla, Repatha, Krystexxa |
| Janssen Pharmaceuticals, INC | $21.71 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.80 | 2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $18.75 | 2022 | |
| Seqirus USA INC | $17.46 | 2025 | Fluad, Flucelvax |
| Exact Sciences Corporation | $17.31 | 2025 | The Cologuard Plus Collection Kit |
| Philips North America LLC | $16.91 | 2022 | |
| Lilly USA, LLC | $14.68 | 2024 | Zepbound, Mounjaro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Deuell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.